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Sonic hedgehog (SHH) is a regulator of forebrain de-
velopment that acts through its receptor, patched 1.
However, little is known about cellular mechanisms
at neurulation, whereby SHH from the prechordal
plate governs specification of the rostral dienceph-
alon ventral midline (RDVM), a major forebrain orga-
nizer. We identified LRP2, a member of the LDL
receptor gene family, as a component of the SHH
signaling machinery in the RDVM. LRP2 acts as an
apical SHH-binding protein that sequesters SHH
in its target field and controls internalization and
cellular trafficking of SHH/patched 1 complexes.
Lack of LRP2 in mice and in cephalic explants results
in failure to respond to SHH, despite functional ex-
pression of patched 1 and smoothened, whereas
overexpression of LRP2 variants in cells increases
SHH signaling capacity. Our data identify a critical
role for LRP2 in SHH signaling and reveal the molec-
ular mechanism underlying forebrain anomalies in
mice and patients with Lrp2 defects.
INTRODUCTION
The developing forebrain arises from a simple neuroepithelial
sheet at the anterior end of the neural plate, the anterior neuro-
ectoderm. During neurulation, initial inductive signals to specify
forebrain midline structures are provided by the prechordal plate
(PrCP), a mesodermal tissue underlying the rostral diencephalon
ventral midline (RDVM). A complex network of signaling path-
ways is necessary for forebrain specification, but one key mole-
cule is the morphogen sonic hedgehog (SHH). SHH signaling
originating in the PrCP acts on the overlying RDVM to establish
ventral forebrain identity. Later, SHH is locally produced in the
RDVM and induces ventral cell populations, and also antago-
nizes dorsal signals provided by bone morphogenetic protein
(BMP) 4 (Hoch et al., 2009; Sousa and Fishell, 2010).
Defects in early forebrain morphogenic pathways often lead
to failure of midline induction and, consequently, to improper268 Developmental Cell 22, 268–278, February 14, 2012 ª2012 Elsevdivision of the forebrain hemispheres. This defect is known as
holoprosencephaly (HPE), the most common forebrain anomaly
in humans (Wallis andMuenke, 1999). Genetic studies in humans
and in animal models have identified a number of causative
genes in HPE (Hayhurst and McConnell, 2003; Roessler and
Muenke, 2010). Mutations in SHH and its downstream effector
genes account for a substantial portion of autosomal dominant
cases (Wallis and Muenke, 1999; Wallis et al., 1999). Also, inac-
tivation of Shh in the mouse results in defective axial patterning
of the neural tube and in failure of separation of the forebrain
hemispheres (Chiang et al., 1996).
Another factor implicated in HPE is the low-density lipoprotein
receptor-related protein (LRP) 2, also known as megalin (Saito
et al., 1994) (hereafter referred to as LRP2). LRP2 is a member
of the LDL receptor gene family expressed on the apical surface
of the neuroepithelium (Willnow et al., 2007). Loss of receptor
activity in gene targeted mice (Spoelgen et al., 2005; Willnow
et al., 1996) or in humans with autosomal recessive LRP2 gene
defects (Donnai-Barrow syndrome) causes HPE-like pheno-
types (Kantarci et al., 2007).
The exact mechanisms by which LRP2 functions in forebrain
development still remain enigmatic. Lack of the receptor in
Lrp2 mutant mice impacts both dorsal and ventral patterning
centers in the early forebrain. Thus, BMP4 signaling in the dorsal
neuroepithelium is increased whereas Shh expression in the
ventral telencephalon is lost (Spoelgen et al., 2005). This obser-
vation suggested a critical yet poorly understood function for
LRP2 in balancing pathways that specify early dorso-ventral
forebrain patterning. Because LRP2 binds both BMP4 and
SHH, a potential role as receptor in either pathway had been
proposed—an open question that remains as yet unresolved.
In this study, we have elucidated the molecular mechanism of
LRP2 in forebrain development and HPE using LRP2-deficient
mouse and cell culture models. Our data demonstrate that
LRP2 is specifically required at the onset of neurulation when
the receptor forms an integral component of the SHH signaling
complex in the ventral midline. It sequesters the PrCP-derived
SHH on the apical surface of the RDVM and controls Patched 1
(Ptch1)-dependent uptake and intracellular trafficking of SHH.
Absence of LRP2 results in the inability to bind SHH at the
ventral neuroepithelial midline and to activate signaling path-
ways through Ptch1 and Smoothened (Smo) in a critical time
window in forebrain specification.ier Inc.
Figure 1. Expression of LRP2 in the Developing Mouse Forebrain
(A–F) Immunohistological detection of LRP2 on horizontal (A and B) and
coronal sections (C–F) of the rostral neuroepithelium of mouse embryos at the
indicated embryonic (E) days. Prior to neural tube closure (E7.5–E8.5; A–D),
LRP2 is expressed uniformly on the apical neuroepithelial surface (white
arrowheads). The square in (A) indicates the area shown in higher magnifica-
tion in (B). After neural tube closure (E9.5E-10.5; E and F), receptor expression
becomes concentrated in the dorsal and ventral midline (arrowheads in E) and
finally restricted to the ventral midline of the developing forebrain (arrowhead
in F).
(G) Immunohistological detection of enhanced green fluorescent protein
(EGFP) on coronal sections of the dorsal and ventral diencephalic region in
Lrp2tmEGFP/+ mice demonstrating strong EGFP expression in the ventral but
significantly lesser expression in the dorsal neuroepithelium. Nuclei were
counterstained with DAPI (blue). Scale bars represent 50 mm.
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Expression of LRP2 in the Developing Forebrain Starts
at Gastrulation
Previous studies aimed at elucidating the consequences of Lrp2
defects for forebrain development focused at midgestation
(E9.5–E10.5) when forebrain malformations are first apparent in
receptor-deficient mice. At this time point, Lrp2/ embryos
are characterized by an overall reduction in size of the telence-
phalic vesicles and by a decrease in neuroepithelial wall thick-
ness (Spoelgen et al., 2005). However, because specification
of the forebrain anlagen starts at gastrulation, molecular defects
in LRP2-deficient mice may well precede the time when first
morphological anomalies are seen.
To identify the exact time point in development when LRP2
activity may first be required, we performed analysis of receptor
expression during gastrulation and early neurulation. Expression
of LRP2was seen as early as E7.5 on the apical side of the devel-
oping neural plate (Figures 1A and 1B) and persisted throughout
later stages of development (Figures 1C and 1D). After neural
tube closure (E9.5), LRP2 expression became progressively re-
stricted to the midline region (Figures 1E and 1F). Distinct ex-
pression in the ventral midline was confirmed by generation of
a reporter mouse carrying a knock-in of the enhanced green
fluorescent protein (EGFP) gene into the start codon of Lrp2.
Expression of EGFP in Lrp2tmEGFP/+ mice faithfully recapitulates
expression of Lrp2 in the neural tube (Figure 1G) and in other
embryonic and adult tissues (data not shown). In the neural
tube at E9.5 and E10.5, EGFP expression was most pronounced
in the ventral midline.
Forebrain Defects in LRP2-Deficient Embryos Initiate
at Early Neurulation
Given the pronounced expression of LRP2 at gastrulation, a
contribution of this receptor to initial steps in forebrain patterning
seemed plausible. However, studies using in situ hybridization
(ISH) failed to reveal any concernable differences in marker
gene expression between genotypes at E7.5 (Figure 2A). Thus,
we turned our attention to neurulation. At E8.0, Shh expression
marks the axial mesendoderm, including the notochord and
PrCP. No differences in Shh expression were seen at this time
point comparing Lrp2/ and control embryos (Figure 2B). Also,
Hesx1 expression in the forebrain anlagen showed a comparable
pattern between genotypes (Figure 2B). However, a severe re-
duction in Six3 levels in the prospective forebrain tissue was
obvious in Lrp2/ embryos (Figure 2B).
Reduced Six3 expression in E8.0 Lrp2/ embryos argued for
an onset of the phenotype at early neurulation. During patterning
of the ventral forebrain, Six3 and Shh mutually control their
expression in a positive regulatory loop (Geng et al., 2008). To
substantiate that changes in Six3 expression reflect defects in
SHH signaling, we carried out a detailed analysis of this mor-
phogen pathway in E8.5 embryos. Whereas in controls, Shh
expression was apparent in the PrCP and in the overlying
RDVM, somite-matched Lrp2/ embryos showed Shh signal
in the PrCP but not in the RDVM (Figure 2C). In addition, expres-
sion of the SHH target genes Gli1 and Six3 was significantly
reduced in the ventral neuroepithelium of LRP2-deficient em-
bryos (Figure 2C). In contrast to the SHH pathway, no obviousDevelopmalterations in other morphogen pathways involved in forebrain
specification were evident. Thus, Bmp4 expression itself was
not detectable in the developing forebrain at E8.5, but expres-
sion in foregut and midline mesendoderm was comparable
between genotypes (Figure 2D). Similarly, Msx2, a target ofental Cell 22, 268–278, February 14, 2012 ª2012 Elsevier Inc. 269
Figure 2. LRP2 Deficiency Impairs SHH-Depen-
dent Signaling during Neurulation
Whole mount in situ hybridization of Lrp2/ and control
mouse embryos at E7.5–E8.5 using markers of forebrain
development. Lateral (A and D) or frontal (B, C, and E)
gastrula or head aspects are shown.
(A) No differences in expression of Hesx1 in visceral
endoderm (arrowheads) or in Six3 that indicates estab-
lishment of the forebrain anlagen in the anterior epiblast
(arrowheads) are seen comparing both genotypes.
Expression of Bmp4 that forms a gradient from the prox-
imal epiblast (asterisks) and of noggin that marks the node
and the adjacent migrating mesendoderm (arrowheads)
show identical patterns in control and in LRP2-deficient
animals.
(B) At neurulation (E8.0), expression domains for Shh and
Hesx1 in the forebrain anlagen are unaffected, but ex-
pression of Six3 is reduced in Lrp2/ animals compared
to controls (dotted lines).
(C) At E8.5, Shh expression is seen in the prechordal plate
and in the overlying neuroepithelium (above the dotted
line) in control embryos. In Lrp2/ embryos, Shh is only
seen in the prechordal plate but fails to be expressed in
the neuroepithelium. Expression of Gli1 and Six3 in the
developing rostral forebrain of mutants is significantly
reduced.
(D and E) No differences in expression are seen at E8.5 for
Bmp4 in foregut (asterisks) and axial mesendoderm
(arrowhead), of Msx2 in the dorsal neuroepithelium
(asterisks), of noggin in the notochord and prechordal
plate (arrowheads), or of Fgf8 in the rostral neural tube
(arrowheads) comparing Lrp2/ and control mouse
embryos at E8.5.
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by loss of LRP2 (Figure 2D). Also, expression of noggin in the
axial mesendoderm and of Fgf8 in the rostral neural tube was
comparable to controls (Figure 2E).
At midgestation (E9.5), forebrain defects in LRP2 mutants
finally manifested themselves in distinct alterations in multiple
morphogen pathways including loss of Shh in the ventral ante-
rior diencephalon and a concomitant increase of Bmp4 in the
dorsal forebrain (Figure S1A available online). Fgf8 showed a
dorsally shifted midline expression extending from the commis-
sural plate while noggin, that marked the midline in control
embryos, exhibited a disrupted pattern in Lrp2/ mutants
(Figure S1A).
Impaired Development of the RDVM Is Caused
by Defects in SHH Distribution
Based on the above data we concluded that loss of SHH
signaling during neurulation represents the primary cause of
forebrain defects in LRP2 mutants. Accordingly, alterations in
other signaling pathways, such as an increase in dorsal BMP4270 Developmental Cell 22, 268–278, February 14, 2012 ª2012 Elsevier Inc.signaling, likely reflected secondary conse-
quences of SHH defects. Our assumption was
supported by the fact that introducing a Bmp4
mutation into Lrp2/ embryos failed to restore
Shh expression in the ventral telencephalon at
E10.5 (Figures S1B and S1C). Similar ap-
proaches have been used successfully before
to rescue developmental defects that arise from enhanced
BMP4 signaling (Stottmann et al., 2006).
SHH protein originating from the PrCP provides the initial
inductive signal to establish its signaling domain in the RDVM
(Geng et al., 2008; Huang et al., 2007). The exact mode of
delivery to its target field is unknown. However, it is clear
that SHH is distinctly targeted to the apical surface of the
ventral neuroepithelium for signal induction (Chamberlain
et al., 2008). Because LRP2 is specifically expressed on the
apical side of the ventral midline and because it has been
shown to bind SHH in vitro (McCarthy et al., 2002), we re-
asoned that this protein may represent a SHH-binding protein
controlling SHH action at the apical surface of the RDVM. To
test this hypothesis, we examined SHH distribution and coloc-
alization with LRP2 during neurulation. Between E8.25 (six
somites; Figure 3B) and E8.5 (eight somites; Figure 3A), SHH
protein was clearly visible in the PrCP and in the RDVM of
control embryos where it colocalized with LRP2 on the apical
surface of the neuroepithelial cells (Figure 3A). Although we
cannot exclude with absolute certainty that some SHH seen
Figure 3. Loss of LRP2 Prevents Formation
of SHH Signaling Center in the Rostral Dien-
cephalon Ventral Midline
(A) Immunohistological detection of SHH (red) and
LRP2 (green) on coronal sections of the RDVM in
control and LRP2-deficient embryos at E8.5–
E8.75. At eight and nine somites (8S, 9S), SHH is
seen in the prechordal plate (arrowhead) and in
the overlying RDVM (above the dotted line) in the
three control embryos shown here. In contrast in
the three matched Lrp2/ animals, significant
amounts of SHH are seen in the prechordal plate
but little to none in the ventral midline. At 11
somites (11S), SHH protein also gradually appears
in the RDVM of mutant embryos.
(B) Coronal forebrain sections showing im-
munohistological detection of SHH (left) as well as
whole mount ISH for Shh (middle) and Six3 (right)
at the indicated developmental stages. In control
embryos, SHH protein localizes from the pre-
chordal plate (below the dotted line) to the over-
lying RDVM, resulting in robust induction of target
genes Shh (ventral midline) and Six3 (rostral neural
tube). In Lrp2/ embryos, failure of SHH protein
to localize from the prechordal plate to the RDVM
at E8.25 and E8.5 results in absent or significantly
reduced signals for Shh and Six3, respectively.
Delayed localization of SHH to the RDVM at E8.75
is unable to rescue proper expression of Shh
and Six3.
(C) Immunohistological detection of SHH (red) on
coronal sections of the diencephalon at E10.5
demonstrating loss of the protein from the ventral
midline in LRP2 mutants (asterisk) compared with
control embryos. Expression of SHH in more
caudal regions of the neural tube such as the
zona limitans intrathalamica (arrowheads) is not
affected by LRP2 deficiency. The lower panels
represent higher magnifications of the ventral
midline region of the sections shown above.
(D) ISH of coronal sections of the RDVM at E10.5
indicating loss of Shh expression but aberrant
induction of Bmp4 and Gli3 in Lrp2/ compared
with control embryos. Scale bars represent 50 mm.
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of Shh transcripts in this tissue at E8.25 (Figure 3B) suggests
that it is mainly PrCP-derived SHH that is seen in the neuroepi-
thelium at this stage. Remarkably, in LRP2-deficient E8.25–
E8.5 embryos (six to ten somite stages), a robust signal for
SHH was seen in the PrCP, but little to no signal in the
RDVM (Figures 3A and 3B). It was only at later time points
around E8.75 (11 somites) that appreciable amounts of SHH
became apparent in the ventral neuroepithelium of mutants
as well (Figure 3A).
Although the delay in appearance of SHH in the RDVM in
LRP2-deficient embryos was only transient (E8.25–E8.5; six to
ten somites), it resulted in a permanent failure to establish
RDVM-specific patterns as exemplified for SHH targets, Shh
itself and Six3 (Figure 3B). Even with SHH protein finally appear-
ing in the RDVM at E8.75 (11 somites), levels of Shh and Six3
stayed drastically reduced compared to controls (Figure 3B).
The apparent decrease in Six3 transcript levels was confirmed
by quantitative RT-PCR on E8.5 forebrain tissue (Figure S2A).
Expression of Ptch1, both receptor but also target of SHHDevelopmwas not affected in E8.5 and E9.5 mutants (Figures S2B
and S3C).
Ultimately, the inability to establish the early SHH signaling
domain in the RDVM of Lrp2/ embryos resulted in severe mis-
patterning of the ventral forebrain after neural tube closure. Thus,
signals for SHH protein (Figure 3C) and the corresponding Shh
transcripts (Figure 3D) were lost from the immediate ventral
midline but mislocalized to more lateral regions of the dienceph-
alon. Also, Bmp4, which is normally suppressed by SHH, and of
Gli3, a repressor of the SHH pathway, were ectopically induced
in this tissue (Figure 3D).
As well as in patterning of the forebrain, SHH also plays an
important role in specification of the spinal cord. However, no
alterations in the SHH expression domains were seen in the
caudal neural tube of Lrp2/ compared with control embryos
at midgestation (Figure S2C). These findings are in line with
earlier reports demonstrating normal patterning of the early
spinal cord in mutants (Spoelgen et al., 2005) and they sup-
port a unique role for this receptor in control of forebrain
development.ental Cell 22, 268–278, February 14, 2012 ª2012 Elsevier Inc. 271
Figure 4. The SHH Pathway Is Functionally
Expressed in LRP2 Mutant Embryos
(A) Scanning electron microscopy of the neuro-
epithelium of LRP2-deficient and control embryos
at E8.5. Arrowheads indicate primary cilia. Scale
bars represent 10 mm (32,000) and 0.5 mm
(310,000).
(B) Detection of LRP2 and Arl13b (top) as well as of
Ptch1 (bottom) on coronal sections of the fore-
brain of the indicated genotypes. The inset depicts
colocalization of LRP2 (green) and Ptch1 (red) in
control forebrain sections. Scale bars represent
12.5 mm (top) and 25 mm (bottom).
(C) ISH for Six3 on whole embryo cultures (WECs)
of control and Lrp2/ embryos at E8.5 and E8.75
following treatment with buffer (w/o SAG) or with
Smoothened agonist (w/ SAG). Loss of Six3
expression in the forebrain anlagen of mutant
embryos (e and g) as compared to controls
(a and c) is rescued by application of SAG
(compare signals in f and h in mutants with b and
d in controls). Rescue was seen in 55% of mutants
(n = 20).
(D) ISH for Shh on cephalic explants of control and
Lrp2/ embryos at E10.5. Expression of Shh in the ventral telencephalon (arrowhead) is seen in untreated wild-type (a) but not in untreated LRP2-deficient
embryos (d). Treatment with SAG rescues expression of Shh in this area of the telencephalon in Lrp2/ embryos (arrows in e and f compared with controls in
b and c). Rescue was seen in 28% of mutants (n = 15).
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in the LRP2-Deficient RDVM
The SHH signaling pathway in the RDVM, comprising the
receptor Ptch1 and its effector Smo, is functionally associated
with the primary cilium of the neuroepithelial cells. Conceivably,
structural anomalies of cilia or dysfunction of Ptch1 or Smo
in neuroepithelial cells lacking LRP2 may be the reason for
impaired SHH signaling in the mutant RDVM.
Using scanning electron microscopy, no discernible abnor-
malities in cellular architecture or in the appearance of primary
cilia were seen in mutant neuroepithelia (Figure 4A). Also, immu-
nohistological detection of ciliary markers Arl13b (Figure 4B) and
acetylated tubulin (Figures S3A and S3B), or of Ptch1 (Figure 4B
and S3A) and Smo (Figure S3B) failed to reveal any obvious
differences between genotypes. Normal Ptch1expression levels
were confirmed by western blot analysis of Lrp2/ embryonic
head extracts (Figure S3C). Conversely, absence of Ptch1 in
Ptch1/ embryos did not impact LRP2 expression (Figure S3D).
In wild-type tissue, LRP2 colocalizes with Ptch1 to the apical
surface of the neuroepithelium (Figure 4B, inset). In line with
a possible activity as an endocytic receptor, LRP2 mainly local-
ized to clathrin-coated pit regions of the apical cell membrane
and to subapical endosomes in this tissue (Figure S3E). LRP2
immunoreactivity was spared from the shaft but clustered at
the base of the primary cilium (Figure S3F).
To prove that Smo in the LRP2-deficient neuroepithelium was
capable of signal transduction, we tested the response of this
tissue to the Smo agonist (SAG). To do so, we applied an
ex vivo model of whole embryo cultures (WECs). In this model,
E7.5–E8.0 embryos were cultured in the presence or absence
of SAG. After 24 hr in culture (E8.5–E8.75), the embryos were
subjected to Six3 ISH. Control embryos showed robust expres-
sion of Six3 in the rostral neural tube with and without the agonist
(Figure 4C, panels a–d). In contrast in Lrp2/ embryos, the Six3272 Developmental Cell 22, 268–278, February 14, 2012 ª2012 Elsevsignal was faint in conditions without SAG (Figure 4C, panels e
and g) but reached levels comparable to that of wild-types after
agonist treatment (Figure 4C, panels f and h).
Rescue of Smo signaling was confirmed in a second ex vivo
model of cephalic explants. When explants from wild-type
embryos, kept in culture from E9.5 to E10.5, were subjected to
Shh ISH, they displayed the characteristic pattern for Shh
including signals in the ventral neural tube rostral to the optic
recess (Figure 4D, panel a). Shh signals were not affected by
treatment with SAG for 24 hr (Figure 4D, panels b and c). In con-
trast, loss of Shh signals in the preoptic area seen in untreated
Lrp2/ explants (Figure 4D, panel d) was rescued by SAG appli-
cation (Figure 4D, panels e and f).
LRP2 Is the Initial Binding Site for SHH in the RDVM
Apparently, components of the SHH signaling machinery are
functional in the LRP2-deficient RDVM. This fact strongly argued
for a critical role of LRP2 upstream in the signaling cascade—
likely in enabling the initial binding of SHH to the apical surface
of the neuroepithelium. This hypothesis was confirmed in cell
culture and in ex vivo models.
In our experiments, we applied the recombinant amino
terminal fragment of SHH (SHH-N) or a fusion protein of gluta-
thione S-transferase and SHH-N (GST-SHH-N), both produced
in bacteria. We also used the lipid-modified form of SHH-N
(SHH-Np) from HEK293 cells stably transfected with a SHH
expression construct. All three ligands were avidly taken up by
Brown Norway rat choriocarcinoma (BN16) cells that express
LRP2. Uptake was blocked by inhibitory anti-LRP2 antibodies
and by the receptor-associated protein (RAP), an established
antagonist of this receptor pathway (Willnow et al., 1992) (Fig-
ures S4A–S4I).
To substantiate the relevance of LRP2 for cellular binding of
SHH in embryos, we applied the recombinant ligands in WECs.ier Inc.
Figure 5. LRP2 Acts as Apical SHH-binding Protein
in the RDVM
(A–H) Immunohistological detection of LRP2 (green) and
SHH (red) on coronal rostral neural tube sections of E8.5
WECs incubated with a fusion protein of GST and SHH-N
(A–D) or with SHH-N (E–H). Absence of LRP2 in Lrp2/
embryos (C and G) results in the inability to bind the
ligands (D and H) compared to control embryos (B and F).
Scale bar represents 50 mm.
(I) Immunofluorescence signals for SHH-N as in (B) and (D)
were scored as relative fluorescence intensities on a
total of 12 sections from four animals in each genotype
(mean ± SEM; p < 0.05).
(K) Colocalization of endogenous SHH (red) and LRP2
(green) on the apical surface and in subapical vesicles
(arrowheads in inset) in the preoptic area of wild-type
E10.5 embryos.
(L) Proximity ligation assay using antisera against LRP2
and SHH on coronal forebrain sections of wild-type and
Lrp2/ WECs (E8.5) treated with GST-SHH-N. Robust
signals are seen in control tissue (arrowheads) indicating
close proximity of receptor and SHH on the apical surface
of the neuroepithelium. The insets represent higher
magnifications of the neuroepithelium in both genotypes.
Scale bar represents 50 mm.
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(Figures 5B and 5F) or with SHH-Np (Figure S4J), binding of
the ligands to the apical neuroepithelial cell surface was evident.
The very same tissue also expressed LRP2 (Figures 5A and 5E).
Colocalization of LRP2 and endogenous SHH in the apical cell
compartment was confirmed by coimmunostaining on forebrain
sections (Figure 5K). Remarkably, no binding of exogenous
GST-SHH-N, SHH-N, (Figures 5D and 5H), or SHH-Np (Fig-
ure S4K) was seen in sections from Lrp2/ WECs. Absence
of ligand binding was confirmed by scoring immunofluores-
cence signal intensities (Figure 5I). This finding strongly argued
that neuroepithelial cells lacking LRP2 are unable to interact
with SHH despite the presence of Ptch1. The ability of LRP2
to act as apical docking site for SHH-N on the neuroepithelial
cell surface was confirmed by PCR-based proximity ligation
assay (PLA). In wild-type WECs treated with GST-SHH-N, a
strong PLA signal was seen at the apical surface of the neural
folds combining anti-LRP2 and anti-SHH antisera indicating
close proximity of ligand and binding protein (Figure 5L). NoDevelopmental Cell 22, 268PLA signal was obtained in GST-SHH-N treated
embryos lacking LRP2 (Figure 5L).
LRP2 Controls Cellular Uptake and
Intracellular Trafficking of SHH
Thus far, the cellular fate of SHH has mainly
been investigated in cultured cells (Incardona
et al., 2002; Incardona et al., 2000; Rohatgi
et al., 2007). Here, we applied WECs to clarify
the cellular pathway of SHH/Ptch1 complexes
in the neuroepithelium and the influence by
LRP2. In unstimulated WECs, Ptch1 mainly
localized to the apical cell surface both in wild-
types and in mutants (Figure 6A). However,
when treated with GST-SHH-N for 2 hr, Ptch1was also seen in intracellular vesicles in wild-types that stained
positive for SHH (Figure 6A). Little intracellular (subapical) signal
for Ptch1 was evident in GST-SHH-N treated mutants, suggest-
ing the necessity of LRP2 for SHH-dependent internalization of
Ptch1. Our conclusion was substantiated by PLA for LRP2 and
Ptch1 demonstrating close proximity of both receptors in the
subapical space of unstimulated and stimulated wild-type (Fig-
ure 6B). Finally, the colocalization of Ptch1, LRP2, and SHH in
wild-type neuroepithelial cells was also confirmed by immuno-
fluorescence microscopy of WEC sections (Figure S5A). Taken
together, our data suggested the existence of a LRP2/Ptch1
coreceptor complex at the neuroepithelial cell surface that
undergoes internalization upon SHH binding. Cellular uptake of
this receptor complex was dependent on clathrin-mediated
endocytosis because it was blocked by the dynamin inhibitor I
(Dynasore; Figure 6C). Lack of internalization of Ptch1/SHH
complexes in LRP2-deficientWECswas not due to a generalized
endocytosis defect as localization and activity of the unre-
lated transferrin receptor was normal (Figure S5B). Also, similar–278, February 14, 2012 ª2012 Elsevier Inc. 273
Figure 6. LRP2 and Ptch1 Form a Coreceptor Complex that Controls SHH Trafficking
(A) Detection of Ptch1 (red) and SHH (green) on coronal rostral neural tube sections of E8.5 WECs incubated with GST or GST-SHH-N. In GST-treated wild-type
and LRP2 mutant embryos, Ptch1 displays a uniform apical staining of neuroepithelial cell surface. In GST-SHH-N stimulated wild-types, Ptch1 is seen in large
subapical vesicles (arrowheads, middle) that also contain SHH (bottom). No Ptch1+ vesicles are apparent in GST-SHH-N treated mutants.
(B) Proximity ligation assay for LRP2 and Ptch1 in E8.5 embryos. In untreated wild-types, close proximity of both receptors is seen at the apical cell surface.
Following treatment with GST-SHH-N, LRP2/Ptch1 complexes also localize to the subapical compartment. No PLA signals are seen in treated or untreated
Lrp2/ WECs.
(C) Detection of SHH, Ptch1, and Rab4 on sections from E8.5 wild-typeWECs treated with GST-SHH-N in the presence of 80 mMDynasore or DMSO vehicle. The
number of Rab4+ early endosomes containing SHH and Ptch1 are significantly reduced in embryos treated with the dynamin inhibitor as compared to the DMSO
control.
(D) Detection of SHH (red) and marker proteins (green) in E8.5 WECs treated with GST-SHH-N. Significant colocalization with SHH is seen for AP2, Rab4, and
Rab11, but little for Lamp1.
(E) Detection of SHH (red) and transferrin (green; left) or SHH (red) and lactoglobulin (green; right) in E8.5 WECs treated with GST-SHH-N and either 50 mg/ml
transferrin-Alexa 674 or 5 mg/ml lactoglobulin-Alexa 546. Complete colocalization is seen for SHH with transferrin but not with lactoglobulin. Lactoglobulin+
vesicles lacking SHH stain for lysosomal marker Lamp1 (red) (merged picture in inset). Scale bars represent 25 mm.
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Lrp2/ neuroepithelial cells (Figure S5C).
To trace the intracellular fate of SHH in more detail, we
costained the protein with markers of endocytic compartments
in wild-type WECs treated with GST-SHH-N (Figure 6D). Signif-
icant colocalization of SHH with AP2 (clathrin-coated pits) and
with Rab4 (early endosomes) was obvious. Little colocalization
was seen with lysosomal marker Lamp1. Rather, extensive co-
localization was observed with Rab11, indicative of recycling
endosomes. To confirm delivery of SHH to the recycling path-
way, we incubated wild-type WECs with GST-SHH-N together
with transferrin or lactoglobulin, ligands targeted to recycling
or lysosomal fate, respectively. Complete overlap of SHH im-
muno-signals with transferrin but only partial overlap with lacto-
globulin was striking (Figure 6E). Similarly, immunoreactivity for
LRP2 and Ptch1 was most obvious in Rab4+ early endosomes
(data not shown) andRab11+ recycling endosomes (Figure S5D),
suggesting predominant recycling rather than lysosomal degra-
dation of receptor/ligand complexes.274 Developmental Cell 22, 268–278, February 14, 2012 ª2012 ElsevLRP2 Mini Receptors Increase Cellular SHH Signaling
Capacity
To finally elucidate the molecular mechanism of LRP2 in SHH
signaling, we performed studies in cell culture models. Because
of the huge size of the LRP2 cDNAprevious attempts to function-
ally express the recombinant protein have failed. Using a PCR-
based cloning approach we identified a 678 amino acid module
in the extracellular domain that, when fused to the transmem-
brane and intracellular portion of LRP2, was able to bind GST-
SHH-N in co-IP experiments (Figures 7A and 7B). To test the
effects of this mini receptor R1 on SHH signaling we followed
the protocol applied to other SHH-binding proteins previously
(Taipale et al., 2000; Zhang et al., 2006). Thus, we transiently
transfected NIH 3T3 cells with a reporter construct encoding a
hedgehog responsive firefly luciferase gene driven by GLI-
binding sites (Sasaki et al., 1997). Cells were cotransfected
with a constitutive Renilla luciferase reporter (as internal control)
and with either the R1 or a control vector. When transfectants
were treated with SHH-Np for 1 or 2 days, an 2-fold higherier Inc.
Figure 7. LRP2 Increases Cellular Sensitivity for SHH
(A) Structure of LRP2 and mini receptor 1 (R1). R1 encompasses the first
cluster of complement-type repeats followed by one EGF precursor homology
domain (amino acids 26–704) fused to the transmembrane and intracellular
receptor domains (amino acids 4382–4660).
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Developminduction in relative firefly luciferase activity was seen in R1 cells
compared to controls (Figure 7C). Induction of firefly luciferase
activity was blocked by the hedgehog pathway inhibitors cyclop-
amine (Figure S6A) and KAAD-cyclopamine (Figure S6B),
demonstrating that R1-dependent SHH signaling works through
Smo. In line with this conclusion, signaling was not affected by
tomatidine, a steroidal alkaloid structurally similar to cyclop-
amine that does not inhibit the hedgehog pathway (Figure S6B).
In conclusion, studies performed in embryos, in ex vivo
models, and in cultured cells all support a model whereby
LRP2 forms a coreceptor complex with Ptch1 for SHH on the
apical surface of cells in the RDVM in a time window critical for
forebrain specification (Figure 7D). This auxiliary binding site
for SHH is required to accumulate the signaling molecule in its
target field and to condition Ptch1-expressing cells to limited
SHH concentrations provided by the PrCP. SHH internalized
by the Ptch1/LRP2 complex is recycled to the apical surface of
the neuroepithelium, presumably to further increase local con-
centration of inductive signals in this forebrain organizer center.
DISCUSSION
LRP2 Is Required for SHH-Dependent Specification
of the RDVM
SHH plays a central role in establishing ventral identity of the
vertebrate neural tube. Its activity in embryonic tissues is con-
trolled by the formation of long- and short-range gradients that
are established by the movement of the secreted factor from
its cellular source into the target field (Ribes and Briscoe,
2009; Sousa and Fishell, 2010). This concept is best understood
for patterning of the caudal neural tubewhere SHH released from
the notochord provides inductive signals to the floor plate, es-
tablishing ventral identity of the developing spinal cord (Placzek,
1995; Ribes and Briscoe, 2009; Roelink et al., 1994). Although
less well characterized than in the spinal cord, SHH gradients
are also critical for specification of the rostral portion of the(B) NIH 3T3 cells transfected with an expression construct for R1 or control
vector (Ctr) were incubated with GST-SHH-N. Subsequently, R1 and ligands
were coimmunoprecipitated using anti-LRP2 IgG. Panel Input represents cell
lysate or media tested for R1 and GST-SHH-N, respectively (lanes 1 and 2).
Panel IP a-LRP2 indicates detection of R1 (a-LRP2) and GST-SHH-N (a-GST)
in immunoprecipitates from cells expressing R1 (lane 3) but not from control
cells (lane 4). Immunoprecipitation experiments without primary antibody
(IP no-IgG) served as negative control.
(C) NIH 3T3 cells were transfected with constructs encoding the Renilla
luciferase gene driven by the constitutive SV40 promoter and the firefly lucif-
erase gene driven by a Gli-responsive promoter element. The transfection mix
also included an expression construct for mini receptor R1 or the empty vector
(Ctr). Subsequently, cell layers were incubated with control medium or with
medium containing SHH-Np. Firefly luciferase activity was determined in
replicate transfectants after 1 or 2 days (d) and expressed as levels relative to
the Renilla luciferase internal control (mean ± SEM). Expression of R1 signifi-
cantly increased relative firefly luciferase activity as compared to controls both
after one (1.8-fold, p = 0.026) and after 2 days (2.2-fold, p = 0.004). RLU,
relative light units.
(D) Model of LRP2 function in SHH signaling. SHH-Np produced in the pre-
chordal plate moves to the RDVM to be sequestered apically by a coreceptor
complex of LRP2 and Ptch1. SHH binding induces uptake of receptor-ligand
complexes and triggers Ptch1-dependent activation of Smo resulting in target
gene induction through GLI. Internalized SHH is delivered to the cellular
recycling pathway to further increase local concentrations.
ental Cell 22, 268–278, February 14, 2012 ª2012 Elsevier Inc. 275
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from the PrCP acts on the overlying neuroectoderm to pattern
the RDVM, the major forebrain organizer center (Geng et al.,
2008; Muenke and Beachy, 2000). Now, we have identified
LRP2 as an integral component of the SHH signaling machinery
in the RDVM critical for forebrain specification and occurrence
of HPE.
An important role for LRP2 in forebrain development had been
recognized previously in mouse models with targeted gene
disruption (Spoelgen et al., 2005). However, exactly when and
by which molecular mechanism this receptor may control fore-
brain specification remained unclear. Our studies now define
the primary function of LRP2 in SHH-dependent signaling in
the rostral ventral midline at early neurulation. This conclusion
is based on the distinct alterations seen in Lrp2/ embryos at
E8.0. At this stage, reduction in Six3 expression in the neuroec-
toderm suggests impaired patterning of the neuroepithelium as
the molecular cause of the developmental defect (Figure 2B).
In line with a reciprocal positive interaction between Six3 and
Shh, expression of Shh and its target Gli1 is also impaired in
the ventral midline of Lrp2/ embryos at E8.5 (Figure 2C).
Further evidence that the SHH pathway is the primary target of
LRP2 activity during neurulation stems from the unperturbed
pattern of other morphogenic pathways such as Bmp4 and
Fgf8 (Figures 2D and 2E) at this early time point and from the
fact that Bmp4 haploinsufficiency did not rescue the Shh pheno-
type of Lrp2/ embryos (Figures S1B and S1C).
LRP2Mediates Sequestration of SHH in the Target Field
Although not elucidated in detail yet, early induction of the RDVM
by SHH likely follows similar mechanisms as shown for its action
in the floor plate. There, ventral sources of SHH from the noto-
chord establish a graded signal that controls spatial patterning
along the dorsal-ventral axis in the spinal cord. Three aspects
are of particular importance for transmission of SHH signals in
this tissue, namely the intrinsic competence of target cells to
respond to the factor, the local concentration of SHH to trigger
the appropriate high threshold targets, as well as the distinct
developmental window for specification (reviewed in Sousa
and Fishell, 2010). LRP2 critically contributes to all three aspects
of SHH signaling in the RDVM.
First, lack of LRP2 results in the inability of target cells in the
RDVM to bind SHH at their apical surface. This statement applies
both to endogenous SHH from the PrCP (Figures 3A and 3B)
and to recombinant ligand added exogenously (Figures 5D
and 5H and S4K). This observation is striking given the fact
that LRP2-deficient cells express Ptch1 (Figures 4B, S2B, and
S3A). In addition, they display ciliary structures (Figures 4A,
S3A, and S3B) and properly respond to Smoothened agonist
(Figures 4C and 4D), indicating functional expression of the
SHH signaling machinery. Thus, LRP2 activity defines the in-
trinsic competence of neuroepithelial cells in the RDVM to re-
spond to an extracellular source of SHH.
In the caudal neural tube, notochord-derived SHH traffics by
a yet unknown mechanism across the neuroepithelial tissue to
accumulate at the apical surface of the neuroectoderm (Cham-
berlain et al., 2008). Because LRP2 is confined to the apical
cell compartments (Figure S3E) and because localization of
SHH into the target field is delayed but not abolished in LRP2-276 Developmental Cell 22, 268–278, February 14, 2012 ª2012 Elsevdeficient mice (Figures 3A and 3B), this receptor is unlikely to
be involved in transport of the factor through the neuroepithelial
cell layer (e.g., by transcytosis). Rather interaction with LRP2
likely serves to sequester SHH molecules at the apical surface
of target cells and to establish high local concentrations in the
RDVM neuroepithelium. Support for a role of LRP2 in local
sequestration of SHH comes from the fact that expression of
Fgf8 is shifted to more dorsal telencephalic regions in Lrp2/
embryos (Figure S1A). Similar effects have been observed in
mice expressing a SHH variant lacking the cholesterol modifica-
tion (ShhN/+) and consequently, exhibiting more widespread
SHH signaling (Huang et al., 2007).
Finally, LRP2 is also critical for regulating temporal aspects of
SHH action. Thus, lack of the receptor results in a transient delay
of SHH targeting to the RDVM from six to ten somites stages
(Figures 3A and 3B). This delay results in a permanent failure to
establish ventral midline identity (Figures 3C and 3D). According
to current hypotheses, a window of competence defines the
proper time point when cells in the floor plate are able to respond
to SHH (Sousa and Fishell, 2010). The fact that SHH finally reach-
ing the RDVM at E8.75 (11 somites) is unable to induce specifi-
cation in LRP2 mutants argues that the activity of this receptor
defines a similar window of competence in the RDVM.
LRP2 Is an SHH-binding Protein Required for Signaling
in the Neuroectoderm
The ability of LRP2 tomediate uptake of recombinant SHH-N has
been shown in cultured cells (McCarthy et al., 2002) and in the rat
epididymis (Morales et al., 2006). However, the significance of
this interaction for SHH signaling in vivo remained obscure. We
now document that LRP2 represents an integral component of
the SHH receptor complex essential for early patterning of the
forebrain. One likely scenario suggests that LRP2 acts as auxil-
iary binding site that locally sequesters SHH and enables target
cells to react to low SHH concentrations in a critical time window
during early neurulation (Figure 7D). Our model is supported by
the close proximity of Ptch1 and LRP2 in the target field (Fig-
ure 6B) and by the inability of LRP2-deficient neuroepithelia to
bind SHH (Figures 5 and S4K) and to mediate SHH-dependent
internalization of Ptch1 (Figure 6A).
Interestingly, several SHH-binding proteins have been identi-
fied that modulate SHH activity. For example Cdo and Boc,
adhesion-like integral membrane proteins function as SHH-
binding protein in the floor plate (Tenzen et al., 2006). Similarly,
the cell surface protein growth arrest-specific gene 1 (GAS1)
binds SHH and facilitates signaling in the developing spinal
cord (Martinelli and Fan, 2007). Cdo expression has also been
shown in the PrCP where it is implicated in the etiology of HPE
(Izzi et al., 2011; Zhang et al., 2006). Our in vivo studies now
demonstrate that a similar pathway is operable in the forebrain
neuroepithelium with LRP2 representing an auxiliary docking
site for SHH in the RDVM. The fact that SHH signaling is normal
in the spinal cord of Lrp2 mutant mice (Figure S2C) argues for
a functional redundancy with other SHH-binding proteins such
as Cdo and Boc in the caudal (Tenzen et al., 2006) but not in
the rostral ventral neural tube. Although we cannot exclude
that some activities of LRP2 essential for SHH signaling in vivo
are lost in the truncated variant R1, the ability of this receptor
variant to increase the response of cultured cells to SHHier Inc.
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positive cells is similar to the effects seen in NIH 3T3 cells when
Cdo is overexpressed (2.5-fold induction) (Zhang et al., 2006) or
when Gas1 is knocked down (2-fold reduction) (Martinelli and
Fan, 2007).
LRP2 Controls Intracellular Trafficking of SHH
Recently, considerable attention has been focused on studying
the cellularmechanisms involved in SHH signaling. Thus, binding
of SHH to Ptch1 at the cell surface results in endocytosis of
ligand-receptor complex (Incardona et al., 2002, 2000; Rohatgi
et al., 2007) and blockade of endocytosis causes failure to
respond to SHH (Incardona et al., 2002, 2000; Rohatgi et al.,
2007). Our data now significantly extend this model demon-
strating SHH-induced internalization of Ptch1 in a dynamin-
dependent manner inWECs (Figure 6C). Intriguingly, internalized
SHHmolecules are mostly delivered to the recycling pathway as
documented by extensive colocalization with Rab11 and trans-
ferrin (Figures 6D and 6E). This observation provides experi-
mental support for earlier hypotheses that recycling of SHH
may serve to further increase local concentrations (Incardona
and Eaton, 2000). Conceptually, interaction with the endocytic
receptor LRP2 may not only suffice to enable SHH binding to
Ptch1 at the neuroepithelial cell surface but may even govern
intracellular transport of SHH through the recycling pathway.
In a previous report, uptake of SHH by LRP2 in BN16 cells was
shown not to deliver the ligand to lysosomal degradation
(McCarthy et al., 2002). These findings make sense in light of
a proposed role for this receptor in recycling of SHH. Clearly,
more studies are required to fully elucidate the cell biology of




Mice with disruption of Lrp2 have been described (Willnow et al., 1996). The
Lrp2 defect was analyzed in receptor-deficient and in somite-matched control
(Lrp2+/+ and Lrp2+/) littermates on a 129SvEmcTer x C57BL/6N genetic back-
ground. Generation of the Lrp2tmEGFP/+ line is described in the supplementary
information. Mice carrying the Bmp4tm1Blh allele were obtained from Jackson
Laboratories (http://www.JAX.org). Ptcneo67/+ embryos were provided by H.
Hahn (University of Go¨ttingen). Protocol for in situ hybridization, immunohistol-
ogy, and quantitative RT-PCR are detailed in the Supplemental Experimental
Procedures. PCR genotyping of E8.0 and older embryos was performed on
yolk sac tissue. Younger embryos were resolved in PCR buffer following
completion of ISH and image acquisition. All experiments involving animals
were performed according to institutional guidelines following approval by
local authorities.
Cephalic Explants and Whole Embryo Culture Experiments
Cephalic explants were prepared as described (Echevarrı´a et al., 2001).
Explants are transferred to dishes and placed (ventricular side facing up) on
floating polycarbonate membrane filters (0.4 mm pore size, culture plate insert,
Millipore) with 10% FCS in DMEM with or without 200 nM SAG (Alexis
Biochemicals). Whole embryo cultures (WECs) were established from E7.5-
to E8.0-old embryos. Embryos were isolated with intact yolk sac and incu-
bated in WEC serum (5 ml/5 embryos; WEC, Harlan Laboratories) for 24 hr.
Explants and WECs were incubated at 37C with 5% CO2 and 95% humidity.
To test SHH-N binding, WECs were incubated for 2 hr in DMEM with 1.5%
BSA containing 5 mg/ml GST-SHH-N (produced in BL21 bacteria using the
pSh1-2tk vector, kindly provided by W.S. Argraves, Medical University of
South Carolina) (McCarthy et al., 2002), 2.5 mg/ml recombinant SHH-N (R&DDevelopmSystems), or conditioned medium from SHHN-293 cells. Yolk sac and amnion
were opened by an incision to enable diffusion of proteins.
Proximity Ligation Assay
Proximity ligation assay (PLA) is a PCR based detection assay to demonstrate
close proximity of two target proteins (Olink Bioscience; http://www.olink.
com). PLA was performed according to manufacturer’s instruction (Duolink II
Brightfield User Manual) on 10 mm cryosections.
Coimmunoprecipitation Experiments
NIH 3T3 cells transfected with R1 or control expression constructs were incu-
bated with 20 mg/ml GST-SHH-N in serum free DMEM for 2 hr. Cells were
washed with PBS, treated with cell-surface linker 3,30-dithiobis-sulfosuccini-
midylpropionate (Pierce), and lysed in Triton X-100/Nonidet P-40-containing
buffer on ice. Immunoprecipitations were performed using anti-LRP2 antisera
and protein G-coupled Sepharose beads.
Luciferase Reporter Assay
NIH 3T3 cells seeded in 6-well plates were transfected with total of 4 mgDNA in
2 ml medium including the R1 expression construct, the Gli-dependent firefly
luciferase reporter (83 30Gli-BSd51LucII) (Sasaki et al., 1997), and a constitu-
tive Renilla luciferase reporter (pRL-SV40; Promega) at amolar ratio of 10:10:1.
In control cells, the R1 plasmid was replaced by the empty vector. The
following day, cells were reseeded into 24-well plates and 24 hr later the
medium was replaced with conditioned medium from control HEK293 cells
or HEK293 cells stably secreting SHH-Np (SHHN-293 cells; kindly pro-
vided M. Kato, Stanford School of Medicine) at a 1:10 dilution in DMEM,
0.5% FCS. The reaction mixture also contained the indicated concentrations
of cyclopamine (Biozol), KAAD-cyclopamine (Calbiochem), or tomatidine
(Calbiochem), or the respective solvent controls. Luciferase assays were per-
formed 24 and 48 hr later using the Dual-Luciferase Reporter Assay System
(Promega). Significance of data was determined by Mann-Whitney test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at doi:10.1016/j.devcel.
2011.11.023.
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